Riskpilot← Back to searchSign inGet full accessBernafon A/S
A/SDissolvedCVR 33763557Kongebakken 9Wholesale of pharmaceutical and medical goods · NACE 4646Est. 2011— employees
Revenue 2024
DKK 636K
-176% vs 2023
EBITDA margin
100.0%
+176% vs 2023
Equity ratio
87.3%
Financial strength
Net profit 2024
DKK 1,8M
+121% vs 2023
| Revenue | DKK 636K | -176% |
| EBITDA | DKK 636K | +176% |
| Net profit | DKK 1,8M | +121% |
| Total assets | DKK 70,5M | +7% |
| Equity | DKK 61,5M | +3% |
| Employees | — | — |
Legal name
Bernafon A/S
CVR number
33763557
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
8. juni 2011
Share capital
DKK 1.500.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsens formand alene, af to bestyrelsesmedlemmer i forening, af et bestyrelsesmedlem i forening med en direktør, af to direktører i forening eller af den samlede bestyrelse.
Address
Kongebakken 9
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | 1.096 | 1.204 | 811 | 785 | 2.349 | -836 | 636 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -4 | -4 | -4 | -4 | -4 | -4 | 746 | 1.041 | 766 | 745 | 2.349 | -836 | 636 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -4 | -4 | -4 | -4 | -4 | -4 | 746 | 1.041 | 766 | 745 | 2.349 | -836 | 636 |
| Net financials | 621 | 614 | 585 | 453 | 343 | 343 | 342 | -8 | -9 | 298 | 1.289 | 1.865 | 1.641 |
| Profit before tax | 617 | 610 | 581 | 449 | 339 | 339 | 1.088 | 1.033 | 757 | 1.043 | 3.638 | 1.029 | 2.277 |
| Tax | 154 | 152 | 143 | 106 | 75 | 75 | 239 | 227 | 168 | 229 | 800 | 226 | 501 |
| Net profit | 463 | 458 | 438 | 343 | 264 | 264 | 849 | 806 | 589 | 814 | 2.838 | 803 | 1.776 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 51.275 | 51.881 | 52.310 | 52.615 | 52.848 | 53.112 | 56.611 | 59.338 | 65.889 | 61.228 | 64.415 | 65.793 | 70.482 |
| Equity | 51.266 | 51.724 | 52.162 | 52.505 | 52.769 | 53.033 | 53.884 | 54.690 | 55.279 | 56.093 | 58.930 | 59.733 | 61.509 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 9 | 157 | 148 | 110 | 79 | 79 | 1.397 | 2.633 | 7.864 | 1.944 | 3.695 | 4.150 | 6.782 |
| Total debt | 9 | 157 | 148 | 110 | 79 | 79 | 1.397 | 2.633 | 7.864 | 1.944 | 3.695 | 4.150 | 6.782 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20122024
Equity ratio
87.3%
This company
38.2%
Market median
+129% vs market
20122024
Return on equity
2.9%
This company
18.4%
Market median
-84% vs market
20122024
Net profit margin
279.2%
This company
8.1%
Market median
+3347% vs market
20122024
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20122024
Debt / equity
0.15×
This company
0.62×
Market median
+76% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KW Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
SB Chief Executive Officer | Chief Executive Officer | 2011 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2011 | — | — | |
| Board of Directors | 2011 | — | — | |
| Chairman | 2017 | — | — | |
| Board of Directors | 2013 | — | — | |
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Demant A/S | Company | 100.0% | 100.0% | 2011 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Bernafon A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karen Wibling Solgård | Chief Executive Officer | 0 companies |
| Svend Børge Foged Thomsen | Chief Executive Officer | 0 companies |
| Niels Jacobsen | Chairman | 0 companies |
| Rasmus Rømeling | Board of Directors | 0 companies |
| Søren Nielsen | Chairman | 0 companies |
| Pelle Kristoffer Munk-Poulsen | Board of Directors | 0 companies |
| René Schneider | Board of Directors | 0 companies |
| Stine Brandenhof Rifsdal | Board of Directors | 0 companies |